E-cigarette cessation and transitions in combusted tobacco smoking status: longitudinal findings from the US FDA PATH Study
Saved in:
Klemperer, E.M., et al., E-cigarette cessation and transitions in combusted tobacco smoking status: longitudinal findings from the US FDA PATH Study. Addiction, vol. 118, n. 6, 2023, p. 1161-1166.
Ref.
586572
Location:
SIIS Archivo (R.696)
Palabras clave:
Drogodependencias, Tabaquismo, Innovaciones, Alternativas, Desintoxicación, Efectos, Abstinencia, Recaída, Riesgo, Estudio longitudinal, Datos estadísticos, EE.UU.
Drogodependencias, Tabaquismo, Innovaciones, Alternativas, Desintoxicación, Efectos, Abstinencia, Recaída, Riesgo, Estudio longitudinal, Datos estadísticos, EE.UU.
Similar Items: E-cigarette cessation and transitions in combusted tobacco smoking status: longitudinal findings from the US FDA PATH Study
- FDA-E-Cigarettes: impact on individual and population health
- Discrimination distress and current combustible and non-combustible tobacco product use among US youth, 2023
- E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys
- Stability of smoking status in the US population: a longitudinal investigation
- E-cigarettes, synthetic nicotine, heated-tobacco and smokeless nicotine delivery products: the nicotine landscape beyond combustible cigarettes
- Indicators of cigarette smoking dependence and relapse in former smokers who vape compared with those who do not: findings from the 2016 International Tobacco Control Four Country Smoking and Vaping Survey